Incidence rates of some cancer types have risen in people under age 50, NCI study shows

Alastair Thompson to lead IU’s breast cancer center

Alastair Thompson was named director of the Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s Vera Bradley Foundation Center for Breast Cancer Research.

August 07, 2026

Vol.52 No.31

In Brief

UCLA researchers receive $3.9M NCI grant to boost the effectiveness of cancer immunotherapy

Cristina Puig-Saus, an associate professor of microbiology, immunology and molecular genetics and surgical oncology at the David Geffen School of Medicine at UCLA and an investigator at the UCLA Health Jonsson Comprehensive Cancer Center, and her research team have received a five-year, $3.9 million grant from NCI to develop drug-based strategies that could enhance cancer immunotherapy for patients with melanoma and potentially other types of cancer.

August 07, 2026

Vol.52 No.31

In Brief

Dana-Farber Department of Pathology receives $2.8M grant from NCI

Dana-Farber Cancer Institute’s Department of Pathology, in collaboration with Brigham and Women’s Hospital, has received renewed funding for the Ruth L. Kirschstein NRSA Institutional Research Training Grant from the NCI, providing resources for pathology residents, clinical fellows, and PhD-trained scientists pursuing research careers in cancer pathology.

August 07, 2026

Vol.52 No.31

Clinical Roundup

BRCA-negative patients may still be high-risk for breast cancer, study finds

Women who test negative for BRCA gene mutations may still be at greater risk of developing breast cancer than the general population, according to a study led by investigators at Cedars-Sinai Medical Center, the University of Toronto, and the University of Sydney.

August 07, 2026

Vol.52 No.31

Clinical Roundup

Anti-Müllerian hormone may help many women with HR+ breast cancer avoid chemotherapy

Researchers at the University of Kansas Cancer Center, Emory University School of Medicine, and the international Southwest Oncology Group Cancer Research Network have identified a blood biomarker that may help thousands of women with hormone receptor-positive breast cancer avoid unnecessary chemotherapy.

August 07, 2026

Vol.52 No.31

Cancer History Project

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”
Chanock and Brawley reflect on their illustrious mentor

If a Mount Rushmore of Epidemiology were to exist, Joseph F. Fraumeni Jr. would be etched into the face of the mountain, former NCI Director Ned Sharpless once told Stephen J. Chanock.

July 31, 2026

Vol.52 No.30

By Sara Willa Ernst

Incidence rates of some cancer types have risen in people under age 50, NCI study shows

YOU MAY BE INTERESTED IN

Alastair Thompson to lead IU’s breast cancer center

UCLA researchers receive $3.9M NCI grant to boost the effectiveness of cancer immunotherapy

Dana-Farber Department of Pathology receives $2.8M grant from NCI

BRCA-negative patients may still be high-risk for breast cancer, study finds

Anti-Müllerian hormone may help many women with HR+ breast cancer avoid chemotherapy

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”
Chanock and Brawley reflect on their illustrious mentor

Renew today!

Subscriber content

Never miss an issue!

Login

Incidence rates of some cancer types have risen in people under age 50, NCI study shows

YOU MAY BE INTERESTED IN

Alastair Thompson to lead IU’s breast cancer center

UCLA researchers receive $3.9M NCI grant to boost the effectiveness of cancer immunotherapy

Dana-Farber Department of Pathology receives $2.8M grant from NCI

BRCA-negative patients may still be high-risk for breast cancer, study finds

Anti-Müllerian hormone may help many women with HR+ breast cancer avoid chemotherapy

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”Chanock and Brawley reflect on their illustrious mentor

Never miss an issue!

Login

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”
Chanock and Brawley reflect on their illustrious mentor